Cardlytics Stock Performance
| CDLX Stock | USD 0.92 0.09 10.78% |
The company retains a Market Sensitivity (Beta) of 1.54, which indicates elevated sensitivity to broad market movements. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Cardlytics will likely underperform. At this point, Cardlytics has a negative expected return of -0.13%.
Risk-Adjusted Performance
Weak
Weak | Strong |
Cardlytics has delivered negative risk-adjusted returns across the last 90 days, suggesting that volatility was not compensated by return. Current market capitalization is about 45.42 Million. Despite latest unsteady performance, the stock's essential indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company's investors. Learn More
1 | Disposition of 14349 shares by Alexis De Sieno of Cardlytics subject to Rule 16 b-3 | 12/31/2025 |
2 | Cardlytics, Inc. Stock Catapults 30 percent Though Its Price And Business Still Lag The Industry | 01/08/2026 |
3 | Acquisition by David Evans of 1000000 shares of Cardlytics subject to Rule 16 b-3 | 01/12/2026 |
4 | PAR Technology to Acquire Bridg, Bringing Loyalty and Non Loyalty Data Together for Smarter Retail and Restaurant Activation | 01/26/2026 |
5 | Benign Growth For Cardlytics, Inc. Underpins Stocks 32 percent Plummet - | 02/05/2026 |
6 | Disposition of 125000 shares by Amit Gupta of Cardlytics subject to Rule 16 b-3 | 02/13/2026 |
7 | Disposition of 52049 shares by Amit Gupta of Cardlytics at 0.902 subject to Rule 16 b-3 | 02/17/2026 |
8 | Disposition of 45159 shares by Amit Gupta of Cardlytics at 0.926 subject to Rule 16 b-3 | 02/18/2026 |
9 | Cardlytics Announces Timing of Its Fourth Quarter and Full Year 2025 Earnings Release | 02/19/2026 |
10 | Acquisition by Amit Gupta of 1500000 shares of Cardlytics subject to Rule 16 b-3 | 02/27/2026 |
11 | Cardlytics Q 4 Earnings Assessment | 03/04/2026 |
12 | Cardlytics, Inc. Q 4 2025 Earnings Call Transcript | 03/06/2026 |
13 | Disposition of 10629 shares by Lynton Nicholas Hollmeyer of Cardlytics subject to Rule 16 b-3 | 03/20/2026 |
14 | Acquisition by Lynton Nicholas Hollmeyer of 1578 shares of Cardlytics subject to Rule 16 b-3 | 03/23/2026 |
| Begin Period Cash Flow | 65.6 M | |
| Total Cashflows From Investing Activities | -15.3 M |
Cardlytics | Build portfolio with Cardlytics Stock |
Relative Risk vs. Return Landscape
If you had invested $ 108.00 in Cardlytics on December 23, 2025 and sold it today you would have lost $ 17.00 from holding Cardlytics or given up 15.74% of portfolio value over 90 days. Cardlytics does not currently generate positive expected returns and carries 5.4182% risk (volatility on return distribution) over a 90-day horizon. In different words, 48% of stocks are less volatile than Cardlytics, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Target Price Odds to finish over Current Price
Price convergence toward a historical mean is a well-documented pattern for stocks like Cardlytics Stock. Although this tendency is a useful forecasting input, some instruments remain persistently mispriced before market correction. Periods of persistent mispricing in some stocks highlight the role of additional risk in pricing dynamics. This framework supports more structured thinking about where Cardlytics Stock price is likely to settle over time.
| Current Price | Horizon | Target Price | Odds moving above the current price in 90 days |
| 0.92 | 90 days | 0.92 | about 65.54 |
Our distribution model estimates the likelihood of Cardlytics moving above the current price in 90 days from now at about 65.54 . The probability is derived from quantitative analysis of this stock's historical price data. Extreme market events can produce outcomes that fall outside the range predicted by normal distributions. Probability analysis is most informative when used as part of a disciplined investment process. (This Cardlytics distribution illustrates the range of expected prices for Cardlytics Stock over a 90-day period). Higher volatility in Cardlytics Stock produces a flatter, wider distribution with more dispersed price expectations. This chart provides a statistical baseline for evaluating Cardlytics Stock's price potential over 90 days. This analysis provides context for understanding the range of possible price paths for Cardlytics Stock.
Cardlytics Price Density |
| Price |
Predictive Modules for Cardlytics
Investors use a wide range of techniques to forecast Cardlytics within the stock market. Combining results from different methods frames the confidence level investors can assign to Cardlytics predictions. Evaluating multiple forecasts helps separate persistent signals from short-term noise in Cardlytics price data. For Cardlytics, the combination of techniques matters more than the precision of any individual forecast.Statistical evidence for mean reversion in Cardlytics' can be observed through its tendency to revert after extreme valuations. Investors who believe in mean reversion view Cardlytics' price extremes as temporary dislocations that may self-correct. Valuation-driven investors use mean reversion to time Cardlytics' investments around historical valuation multiples. Historical data for Cardlytics shows that extreme valuations have tended to normalize over multi-year periods.
Primary Risk Indicators
Significant market corrections and rallies over the last two decades have made the stock market challenging for Cardlytics investors. Dramatic market moves have periodically reshaped the risk landscape for holders of Cardlytics. Watching for changes in Cardlytics' volatility and market elasticity is one way to limit portfolio losses. A data-driven view of Cardlytics risk supports more disciplined portfolio management decisions.α | Alpha over Dow Jones | -0.0621 | |
β | Beta against Dow Jones | 1.54 | |
σ | Overall volatility | 0.20 | |
Ir | Information ratio | -0.0215 |
Investor Alerts and Insights
Tracking Cardlytics through automated alerts focuses attention on the most impactful stock developments. Reviewing Cardlytics notifications is an efficient way to stay current on technical patterns and fundamental changes. Systematic monitoring of Cardlytics through automated alerts reduces the risk of missing critical developments. Automated alert systems provide consistency that manual monitoring of Cardlytics cannot match.| Cardlytics generated a negative expected return over the last 90 days | |
| Cardlytics has high historical volatility and very poor performance | |
| Cardlytics has some characteristics of a very speculative penny stock | |
| Cardlytics has a very high chance of going through financial distress in the upcoming years | |
| Cardlytics currently holds $215.31 M in liabilities with Debt to Equity (D/E) ratio of 0.42, which is broadly in line with comparable companies. Cardlytics has a current ratio of 0.88, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Cardlytics' use of debt, we should always consider it together with its cash and equity. | |
| The company reported previous year's revenue of 233.27 M. Net Loss for the year was -103.49 M with profit before overhead, payroll, taxes, and interest of 104.61 M. | |
| Latest headline from insidermonkey.com: Cardlytics, Inc. Q 4 2025 Earnings Call Transcript |
Price Density Drivers
Several forces contribute to Cardlytics' price dynamics, including buyer and seller positioning dynamics and market conditions. Monitoring Cardlytics' price density drivers provides context for distinguishing fundamental from tactical price moves. Key market indicators for Cardlytics reflect the combined effect of buyer and seller positioning dynamics and broader conditions. These indicators are most useful when reviewed consistently alongside Cardlytics's fundamental data.
| Common Stock Shares Outstanding | 53.1 M | |
| Cash And Short Term Investments | 48.7 M |
Cardlytics Fundamentals Growth
Market participants price Cardlytics Stock based on their assessment of Cardlytics' financial trajectory. Revenue and earnings growth, profitability metrics, and debt levels form the core fundamentals driving Cardlytics Stock. Revenue growth, earnings performance, and balance sheet health are critical fundamentals shaping Cardlytics Stock. Long-term performance of Cardlytics Stock depends on Cardlytics' ability to maintain strong fundamental execution.
| Return On Equity | -3.26 | |||
| Return On Asset | -0.0869 | |||
| Profit Margin | -0.44 % | |||
| Operating Margin | -0.1 % | |||
| Current Valuation | 211.79 M | |||
| Shares Outstanding | 55.05 M | |||
| Price To Earning | -3.47 X | |||
| Price To Book | 1.58 X | |||
| Price To Sales | 0.19 X | |||
| Revenue | 233.27 M | |||
| Gross Profit | 104.61 M | |||
| EBITDA | -19.73 M | |||
| Net Income | -103.49 M | |||
| Cash And Equivalents | 157.04 M | |||
| Cash Per Share | 4.77 X | |||
| Total Debt | 215.31 M | |||
| Debt To Equity | 0.42 % | |||
| Current Ratio | 0.90 X | |||
| Book Value Per Share | -0.12 X | |||
| Cash Flow From Operations | 9.29 M | |||
| Earnings Per Share | -1.95 X | |||
| Market Capitalization | 45.42 M | |||
| Total Asset | 285.64 M | |||
| Retained Earnings | -1.4 B | |||
| Working Capital | 58.89 M | |||
| Current Asset | 81.93 M | |||
| Current Liabilities | 52.77 M | |||
Performance Metrics & Calculation Methodology
Cardlytics performance is measured on a risk-adjusted basis against benchmarks. Upside capture and downside containment can vary by regime. Cardlytics shows ROE of -3.26%, ROA of -8.69%.
Unless otherwise specified, data for Cardlytics is compiled from periodic company reporting and market reference feeds and standardized for comparability. Updates may occur throughout the day. Return and risk statistics are calculated from historical price series.